CARGO Therapeutics Provides Corporate Update
Provided By GlobeNewswire
Last update: Mar 18, 2025
- Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize shareholder value -
Read more at globenewswire.com
